SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

25 Oct 2024 Evaluate
The sales declined to Rs. 1657.00 millions for the September 2024 quarter as compared to Rs. 1863.00 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2024 of Rs. 105.00 millions grew from Rs.-4.00 millionsOperating Profit saw a handsome growth to 377.00 millions from 192.00 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1657.00 1863.00 -11.06 3324.00 4037.00 -17.66 7847.00 8101.00 -3.14
Other Income 438.00 184.00 138.04 633.00 343.00 84.55 1034.00 1379.00 -25.02
PBIDT 377.00 192.00 96.35 584.00 393.00 48.60 1199.00 1410.00 -14.96
Interest 78.00 71.00 9.86 154.00 135.00 14.07 299.00 185.00 61.62
PBDT 299.00 121.00 147.11 318.00 258.00 23.26 900.00 1225.00 -26.53
Depreciation 133.00 119.00 11.76 264.00 233.00 13.30 483.00 432.00 11.81
PBT 166.00 2.00 8200.00 54.00 25.00 116.00 417.00 793.00 -47.41
TAX 61.00 6.00 916.67 51.00 10.00 410.00 101.00 294.00 -65.65
Deferred Tax 8.00 6.00 33.33 -2.00 6.00 -133.33 33.00 156.00 -78.85
PAT 105.00 -4.00 -2725.00 3.00 15.00 -80.00 316.00 499.00 -36.67
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 22.75 10.31 120.76 17.57 9.73 80.47 15.28 17.41 -12.21

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×